GluOC Induced SLC7A11 and SLC38A1 to Activate Redox Processes and Resist Ferroptosis in TNBC
Open Access
Abstract
Background/Objectives: Ferroptosis, a type of programmed cell death, is mainly associated with disruptions in iron metabolism, imbalances in the amino acid antioxidant system, and the build-up of lipid peroxides. Triple-negative breast cancer (TNBC) has a dismal prognosis. Since activating ferroptosis can suppress breast cancer cell proliferation, it holds promise as a novel therapeutic target for breast cancer patients. Thus, the objective of this study was to clarify the mechanism of ferroptosis in TNBC, aiming to find new treatment strategies for TNBC patients. Methods: We screened out the differential genes related to ferroptosis in TNBC after GluOC treatment based on the whole-genome sequencing results. At the cellular level, we conducted explorations using techniques such as quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting, fluorescence staining, and siRNA transfection. Moreover, we further verified the role of GluOC in inhibiting ferroptosis in TNBC through in vivo experiments using nude mice. Results: The results showed that GluOC enhanced glutathione expression levels by inducing SLC7A11 accumulation via the specific signaling pathway. Additionally, GluOC increased ATP production and tricarboxylic acid flux resistance to ferroptosis through SLC38A1. Overall, GluOC coordinately regulated SLC7A11 and SLC38A1 to inhibit ferroptosis in TNBC. Conclusions: This study elucidated the mechanism of GluOC in inhibiting ferroptosis in TNBC. The findings not only provided new insights into ferroptosis but also potentially offered new concepts for the development of future anticancer therapies, which may contribute to improving the treatment of TNBC patients.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (E2E43202X2)
This publication has 46 references indexed in Scilit:
- CENPA promotes glutamine metabolism and tumor progression by up-regulating SLC38A1 in endometrial cancerCellular Signalling, 2024
- Nicorandil Regulates Ferroptosis and Mitigates Septic Cardiomyopathy via TLR4/SLC7A11 Signaling PathwayInflammation, 2023
- Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancerBiomedicine & Pharmacotherapy, 2023
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapyProtein & Cell, 2020
- Glutamine transporters as pharmacological targets: From function to drug designAsian Journal of Pharmaceutical Sciences, 2020
- Dysregulation of glutaminase and glutamine synthetase in cancerCancer Letters, 2019
- The PI3K Pathway in Human DiseaseCell, 2017
- Glutamine transporters in mammalian cells and their functions in physiology and cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progressionCellular and Molecular Life Sciences, 2015
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012